Delcath’s Percutaneous Hepatic Perfusion (PHP) technology allows physicians to deliver significantly higher doses of existing chemotherapy drugs to the liver without exposing each patient’s entire body to the anti-cancer drugs.
Jennerex Raises $5.1 Million for Oncology Pipeline
Vaccine company Jennerex has raised $5.1 million in a Series C round of financing.
